8-K current report · filed Nov 12, 2026

NeuroPace Inc (NPCE) 8-K Current Report: November 12, 2026

Item 2.02Item EX-99.1NPCE overview

Short answer

NeuroPace Inc (NPCE) filed an 8-K current report with the SEC on November 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Press release covers NeuroPace’s financial results for the quarter ended September 30, 2026.

NeuroPace Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Press release covers NeuroPace’s financial results for the quarter ended September 30, 2026
  • Investors should review Exhibit 99.1 for revenue, profitability, cash flow and management commentary

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $23.1M, down 1.1% YoY, with RNS revenue $22.9M, up 1.4%, signaling stalled commercial momentum
  • GAAP net loss narrowed to $3.3M from $4.9M, while Adjusted EBITDA improved to $0.4M from negative $1.3M
  • 2026 revenue guidance cut to $91M-$92M from $99.5M-$101.5M, reflecting account issues and field-organization disruption
  • Cash, investments and restricted cash $49.5M versus $51.9M prior quarter, against $59.2M long-term borrowings
  • Remote Care FDA submission and planned IGE amendment create regulatory growth catalysts, alongside AURORA adolescent-study enrollment

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other NeuroPace Inc 8-K filings

Get the next NPCE 8-K as it lands

Follow NPCE for push alerts, or ask the research agent what this filing means.